AHRQ adds new guides to supplement ischemic heart disease comparative effectiveness review
Research Activities, September 2010, No. 361
The Agency for Health Care Research and Quality (AHRQ) Effective Health Care (EHC) Program has added new materials relevant to the comparative effectiveness review, Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease.
Learn how you can personalize your interactions with and share what you learn on the EHC Program Web site. Visit http://www.effectivehealthcare.ahrq.gov/index.cfm/personalization-and-social-media-tools.
Current as of September 2010
Internet Citation: AHRQ adds new guides to supplement ischemic heart disease comparative effectiveness review: Research Activities, September 2010, No. 361.
September 2010. Agency for Healthcare Research and Quality, Rockville, MD. http://archive.ahrq.gov/news/newsletters/research-activities/sep10/0910RA43.html